Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P46
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -1.33% |
| Q3 2025 | -33.41% |
| Q2 2025 | 98.64% |
| Q1 2025 | -5.56% |
| Q4 2024 | 9.57% |
| Q3 2024 | 38.92% |
| Q2 2024 | 23.72% |
| Q1 2024 | -14.04% |
| Q4 2023 | 19.12% |
| Q3 2023 | 4.09% |
| Q2 2023 | 2.86% |
| Q1 2023 | -50.74% |
| Q4 2022 | 129.86% |
| Q3 2022 | -23.01% |
| Q2 2022 | 73.25% |
| Q1 2022 | -16.60% |
| Q4 2021 | -6.87% |
| Q3 2021 | -18.15% |
| Q2 2021 | -67.61% |
| Q1 2021 | 345.15% |
| Q4 2020 | -0.66% |
| Q3 2020 | 15.93% |
| Q2 2020 | -71.69% |
| Q1 2020 | 265.30% |
| Q4 2019 | -25.92% |
| Q3 2019 | 103.52% |
| Q2 2019 | -19.34% |
| Q1 2019 | -66.77% |
| Q4 2018 | 685.43% |
| Q3 2018 | 172.97% |
| Q2 2018 | 115.63% |
| Q1 2018 | 2.76% |
| Q4 2017 | -16.68% |
| Q3 2017 | 14.02% |
| Q2 2017 | -31.07% |
| Q1 2017 | -1.83% |
| Q4 2016 | 30.43% |
| Q3 2016 | -39.86% |
| Q2 2016 | 32.49% |
| Q1 2016 | -63.77% |